Patents by Inventor Vivek R. Nerurkar

Vivek R. Nerurkar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5397696
    Abstract: The present invention relates to a human T-cell line (PNG-1) persistently infected with a Papua New Guinea (PNG) HTLV-I variant and to the infecting virus (PNG-1 variant). Cells of the present invention express viral antigens, type C particles and have a low level of reverse transcriptase activity. The establishment of this cell line, the first of its kind from an individual from Papua New Guinea, makes possible the screening of Melanesian populations using a local virus strain. The present invention also relates to vaccines for use in humans against infection with and diseases caused by HTLV-I and related viruses. The invention further relates to a variety of bioassays and kits for the detection and diagnosis of infection with and diseases caused by HTLV-I and related viruses.
    Type: Grant
    Filed: August 12, 1991
    Date of Patent: March 14, 1995
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Richard Yanagihara, Vivek R. Nerurkar, Carol Jenkins, Mark Miller, Ralph M. Garruto